Table 1.
Number and age-standardized prevalence, incidence, mortality, YLLs, YLDs and DALY rates in 2019 for thyroid cancer in Asia.
| South Asia | Southeast Asia | High-income Asia-Pacific | Oceania | |||||
|---|---|---|---|---|---|---|---|---|
| Age-standardized rate per 100,000 | Total | Age-standardized rate per 100,000 | Total | Age-standardized rate per 100,000 | Total | Age-standardized rate per 100,000 | Total | |
| DALYS | 16.15 (14.09–18.32) |
291,574.64 (254,403.38–330,796.42) |
24.39 (20.26–27.90) |
164,303.52 (136,533.58–187,955.55) |
26.17 (22.24–29.19) |
49,019.24 (41,648.17–54,668.39) |
1.22 (0.86–1.65) |
1576.43 (1156.35–2176.44) |
| DEATHS | 0.51 (0.44–0.58) |
9195.55 (7978.03–10,476.58) |
0.87 (0.74–0.99) |
5862.06 (4999.36–6646.13) |
1.47 (1.14–1.64) |
2754.35 (2127.72–3071.31) |
0.38 (0.28–0.51) |
50.20 (37.29–68.12) |
| Prevalence | 12.55 (10.48–14.61) |
226,466.71 (189,125.73–263,768.63) |
28.93 (22.85–34.25) |
194,898.69 (153,975.46–230,803.05) |
65.97 (56.07–76.34) |
123,548.32 (105,011.59–142,979.40) |
11.87 (8.71–16.39) |
1114.43 (765.4–1521.53) |
| Incidence | 1.75 (1.47–2.02) |
31,533.90 (26,591.47–36,439.30) |
3.80 (3.05–4.44) |
25,581.44 (20,569.12–29,885.75) |
8.36 (7.01–9.64) |
15,659.75 (13,134.42–18,056.29) |
11.30 (8.23–15.62) |
161.67 (113.9–219.59) |
| YLDS | 0.80 (0.54–1.12) |
14,455.20 (9657.83–20,221.79) |
1.82 (1.20–2.55) |
12,235.22 (8065.08–17,164.50) |
4.10 (2.76–5.78) |
7677.56 (5160.56–10,820.34) |
0.57 (0.35–0.89) |
76.05 (45.84–118.68) |
| YLLS | 15.35 (13.42–17.49) |
277,119.44 (242,233.44–315,799.76) |
22.57 (18.76–25.90) |
152,068.30 (126.427.00–174.530.60) |
22.07 (18.37–24.16) |
41,341.68 (34,412.42–45,253.98) |
8.39 (5.77–11.46) |
1500.38 (1092.36–2073.39) |
| Asia | Central Asia | East Asia | ||||||
| Age-standardized rate per 100,000 | Total | Age-standardized rate per 100,000 | Total | Age-standardized rate per 100,000 | Total | |||
| DALYS | 16.49 (14.6–18) |
750,983.75 (665,082.63–819,813.37) |
9.87 (8.77–11.04) |
9231.30 (8202.92–10,321.49) |
13.40 (11.22–15.52) |
197,337.06 (165,223.90–228,530.15) |
||
| DEATHS | 0.59 (0.53–0.65) |
26,982.24 (23,978.01–29,390.85) |
0.33 (0.30–0.36) |
308.74 (278.41–340.85) |
0.52 (0.43–0.60) |
7620.95 (6346.14–8874.16) |
||
| Prevalence | 2.79 (18.82–23.77) |
127,008.06 (857,343.77–1,082,418.36) |
12.25 (10.83–13.87) |
11,453.95 (10,131.17–12,975.29) |
22.46 (18.66–27.41) |
330,694.28 (274,742.67–403,528.00) |
||
| Incidence | 1.34 (2.44–3.07) |
61,060.65 (111,148.68–139,719.56) |
1.57 (1.40–1.76) |
1467.37 (1305.66–1649.90) |
2.82 (2.36–3.41) |
41,579.53 (34,750.62–50,204.07) |
||
| YLDS | 21.57 (0.91–1.83) |
982,341.15 (41,231.73–83,495.88) |
0.77 (0.52–1.06) |
719.03 (488.29–995.01) |
1.38 (0.91–1.99) |
20,386.07 (13,431.75–29,297.95) |
||
| YLLS | 15.15 (13.42–16.6) |
689,923.10 (611,277.65–756,008.82) |
9.10 (8.15–10.13) |
8512.26 (7624.29–9470.82) |
12.02 (10.07–14.09) |
176,950.98 (148,178.28–207,487.06) |
||
DALYs, disability-adjusted life year; YLDs, years lived with disability; YLLs, years of life lost.